Cargando…
Correction to: Efgartigimod: First Approval
Autor principal: | Heo, Young-A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9015989/ https://www.ncbi.nlm.nih.gov/pubmed/35353355 http://dx.doi.org/10.1007/s40265-022-01712-4 |
Ejemplares similares
-
Efgartigimod: First Approval
por: Heo, Young-A
Publicado: (2022) -
Correction to: Efgartigimod Alfa in Generalised Myasthenia Gravis: A Profile of Its Use
por: Heo, Young-A
Publicado: (2023) -
Correction to: Satralizumab: First Approval
por: Heo, Young-A
Publicado: (2020) -
Correction to: Revefenacin: First Global Approval
por: Heo, Young-A
Publicado: (2019) -
Correction to: Andexanet Alfa: First Global Approval
por: Heo, Young-A
Publicado: (2018)